If you’re wondering what’s next for Teva Pharmaceutical Industries (NYSE:TEVA), the company’s latest move might catch your ...

Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs ...

The Food and Drug Administration is cracking down on ingredients from potentially from unverified foreign sources and that ...

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the ...

Idaho’s health insurance plan for state employees will stop covering prescription medication for weight loss on Nov. 1. In a ...

In December 2024, Teva also secured FDA approval for the other liraglutide brand Victoza, indicated for type 2 diabetes.

A Blue Cross Blue Shield study of one decade worth of claims for Saxenda and Wegovy found 58% of patients quit the weight-loss drugs after 12 weeks.

The cost of Saxenda (liraglutide’s brand name) varies depending on treatment plan, insurance coverage and pharmacy, but according to Novo Nordisk, the monthly list price of the drug is $1,349.02.

In the ever-evolving symphony of weight loss medications, Saxenda (Liraglutide) has long taken center stage as a virtuoso in pharmaceutical solutions for shedding unwanted pounds. Yet, the search ...

The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers report.